Wilson N M, Silverman M
Department of Paediatrics and Neonatal Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London.
Arch Dis Child. 1990 Apr;65(4):407-10. doi: 10.1136/adc.65.4.407.
In a double blind, controlled trial, the effect of high dose beclomethasone dipropionate (750 micrograms three times daily for five days) administered by metered dose inhaler and valved spacer, was compared with placebo, during 70 paired episodes of acute asthma in 24 preschool children. Treatment commenced at home at the first sign of an attack. Parents' blind preference for active treatment was significant. Data from 17 pairs of treatment, however, were affected by interventions such as hospital admission or oral corticosteroid treatment. These events occurred similarly in active and control periods. An intrasubject comparison was made of diary scores from the 18 pairs of episodes in which no intervention occurred in either the active or placebo treatment. Both daytime and night symptoms over the first week of the attack were significantly reduced by active treatment. Intermittent high dose inhaled beclomethasone dipropionate is beneficial in modifying the severity of acute episodic asthma in preschool children able to use a spacer device.
在一项双盲对照试验中,对24名学龄前儿童的70对急性哮喘发作进行研究,比较了通过定量吸入器和带瓣储雾罐给予高剂量二丙酸倍氯米松(每日三次,每次750微克,共五天)与安慰剂的效果。治疗在发作的首个迹象出现时在家中开始。家长对活性治疗的盲目偏好显著。然而,17对治疗的数据受到诸如住院或口服皮质类固醇治疗等干预的影响。这些事件在活性治疗期和对照期的发生情况相似。对18对发作的日记评分进行了受试者内比较,在这些发作中,活性治疗或安慰剂治疗均未发生干预。活性治疗显著降低了发作第一周的白天和夜间症状。间歇性高剂量吸入二丙酸倍氯米松有助于改善能够使用储雾罐装置的学龄前儿童急性发作性哮喘的严重程度。